Literature DB >> 29733549

Toxicological Profiling of Highly Purified Single-Walled Carbon Nanotubes with Different Lengths in the Rodent Lung and Escherichia Coli.

Xiang Wang1,2, Jae-Hyeok Lee3,4, Ruibin Li5, Yu-Pei Liao1, Joohoon Kang3, Chong Hyun Chang2, Linda M Guiney3, Vahid Mirshafiee2, Linjiang Li2, Jianqin Lu1, Tian Xia1,2, Mark C Hersam3,6, André E Nel1,2.   

Abstract

Carbon nanotubes (CNTs) exhibit a number of physicochemical properties that contribute to adverse biological outcomes. However, it is difficult to define the independent contribution of individual properties without purified materials. A library of highly purified single-walled carbon nanotubes (SWCNTs) of different lengths is prepared from the same base material by density gradient ultracentrifugation, designated as short (318 nm), medium (789 nm), and long (1215 nm) SWCNTs. In vitro screening shows length-dependent interleukin-1β (IL-1β) production, in order of long > medium > short. However, there are no differences in transforming growth factor-β1 production in BEAS-2B cells. Oropharyngeal aspiration shows that all the SWCNTs induce profibrogenic effects in mouse lung at 21 d postexposure, but there are no differences between tube lengths. In contrast, these SWCNTs demonstrate length-dependent antibacterial effects on Escherichia coli, with the long SWCNT exerting stronger effects than the medium or short tubes. These effects are reduced by Pluronic F108 coating or supplementing with glucose. The data show length-dependent effects on proinflammatory response in macrophage cell line and antibacterial effects, but not on collagen deposition in the lung. These data demonstrate that over the length scale tested, the biological response to highly purified SWCNTs is dependent on the complexity of the nano/bio interface.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibacterial effects; density gradient ultracentrifugation (DGU); length sorting; lung fibrosis; single-walled carbon nanotubes (SWCNTs)

Mesh:

Substances:

Year:  2018        PMID: 29733549      PMCID: PMC6239219          DOI: 10.1002/smll.201703915

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  46 in total

1.  Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials.

Authors:  Xiang Wang; Matthew C Duch; Nikhita Mansukhani; Zhaoxia Ji; Yu-Pei Liao; Meiying Wang; Haiyuan Zhang; Bingbing Sun; Chong Hyun Chang; Ruibin Li; Sijie Lin; Huan Meng; Tian Xia; Mark C Hersam; André E Nel
Journal:  ACS Nano       Date:  2015-02-18       Impact factor: 15.881

2.  Antibacterial effects of carbon nanotubes: size does matter!

Authors:  Seoktae Kang; Moshe Herzberg; Debora F Rodrigues; Menachem Elimelech
Journal:  Langmuir       Date:  2008-05-30       Impact factor: 3.882

3.  Multiwall carbon nanotubes mediate macrophage activation and promote pulmonary fibrosis through TGF-β/Smad signaling pathway.

Authors:  Peng Wang; Xin Nie; Yue Wang; Yang Li; Cuicui Ge; Lili Zhang; Liming Wang; Ru Bai; Zhiyun Chen; Yuliang Zhao; Chunying Chen
Journal:  Small       Date:  2013-05-06       Impact factor: 13.281

4.  Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura.

Authors:  Fiona A Murphy; Craig A Poland; Rodger Duffin; Khuloud T Al-Jamal; Hanene Ali-Boucetta; Antonio Nunes; Fiona Byrne; Adriele Prina-Mello; Yuri Volkov; Shouping Li; Stephen J Mather; Alberto Bianco; Maurizio Prato; William Macnee; William A Wallace; Kostas Kostarelos; Ken Donaldson
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  Perturbation of the pulmonary surfactant monolayer by single-walled carbon nanotubes: a molecular dynamics study.

Authors:  Yan Xu; Zhen Luo; Shixin Li; Weiguo Li; Xianren Zhang; Yi Y Zuo; Fang Huang; Tongtao Yue
Journal:  Nanoscale       Date:  2017-07-27       Impact factor: 7.790

6.  NADPH Oxidase-Dependent NLRP3 Inflammasome Activation and its Important Role in Lung Fibrosis by Multiwalled Carbon Nanotubes.

Authors:  Bingbing Sun; Xiang Wang; Zhaoxia Ji; Meiying Wang; Yu-Pei Liao; Chong Hyun Chang; Ruibin Li; Haiyuan Zhang; André E Nel; Tian Xia
Journal:  Small       Date:  2015-01-12       Impact factor: 13.281

7.  Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury.

Authors:  Xiang Wang; Tian Xia; Matthew C Duch; Zhaoxia Ji; Haiyuan Zhang; Ruibin Li; Bingbing Sun; Sijie Lin; Huan Meng; Yu-Pei Liao; Meiying Wang; Tze-Bin Song; Yang Yang; Mark C Hersam; André E Nel
Journal:  Nano Lett       Date:  2012-05-04       Impact factor: 11.189

8.  Identification and Optimization of Carbon Radicals on Hydrated Graphene Oxide for Ubiquitous Antibacterial Coatings.

Authors:  Ruibin Li; Nikhita D Mansukhani; Linda M Guiney; Zhaoxia Ji; Yichao Zhao; Chong Hyun Chang; Christopher T French; Jeff F Miller; Mark C Hersam; Andre E Nel; Tian Xia
Journal:  ACS Nano       Date:  2016-11-28       Impact factor: 15.881

9.  Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.

Authors:  James C Bonner
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-25

10.  Microbial cytotoxicity of carbon-based nanomaterials: implications for river water and wastewater effluent.

Authors:  Seoktae Kang; Meagan S Mauter; Menachem Elimelech
Journal:  Environ Sci Technol       Date:  2009-04-01       Impact factor: 9.028

View more
  3 in total

Review 1.  Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.

Authors:  Qi Liu; Xiang Wang; Tian Xia
Journal:  Anal Bioanal Chem       Date:  2018-08-01       Impact factor: 4.142

Review 2.  Nanoparticle-Based Activatable Probes for Bioimaging.

Authors:  Tiancong Ma; Tian Xia
Journal:  Adv Biol (Weinh)       Date:  2021-01-04

Review 3.  Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication.

Authors:  Chenyang Xiang; Yuxuan Zhang; Weisheng Guo; Xing-Jie Liang
Journal:  Acta Pharm Sin B       Date:  2019-11-06       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.